Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib. (26th November 2018) - Mian, Michael; Pescosta, Norbert; Badiali, Stefania; Cappelletto, Paola Cristina; Marcheselli, Luigi; Luminari, Stefano; Patriarca, Francesca; Zambello, Renato; Pascarella, Anna; Tagariello, Giuseppe; Marabese, Alessandra; Mondello, Patrizia; et al.